Cytokine gene polymorphism among Indigenous Australians

Innate Immunity

Volumn 20, Issue 4, 2014, Pages 431-439

  Cox, Amanda J ^a,b   Moscovis, Sophia M ^a,b   Blackwell, C Caroline ^a,b   Scott, Rodney J ^a,b,c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^c JOHN HUNTER HOSPITAL   (Australia)

Author keywords

Indigenous Australians; inflammatory cytokines; Sequence variants

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; AUSTRALIA; CAUCASIAN; CHINESE; COMMUNITY; CONTROLLED STUDY; ETHNIC AND RACIAL GROUPS; GENE FREQUENCY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE MAP; HUMAN; INFLAMMATION; LIFESTYLE; MAJOR CLINICAL STUDY; NIGERIA; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; COMPARATIVE STUDY; GENETICS; OCEANIC ANCESTRY GROUP; POPULATION GROUP; RISK REDUCTION;

ADULT; AUSTRALIA; CYTOKINES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENOTYPE; HUMANS; INFLAMMATION; OCEANIC ANCESTRY GROUP; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION GROUPS; RISK REDUCTION BEHAVIOR;

EID: 84898982340     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425913498911     Document Type: Article

References (32)

1. The health and welfare of Australia's Aboriginal and Torres Strait Islander peoples. Canberra: Australian Bureau of Statistics ; 2008 :
2. Zhao Y, Dempsey K. Causes of inequality in life expectancy between Indigenous and non-Indigenous people in the Northern Territory, 1981-2000: a decomposition analysis. Med J Aust. 2006 ; 184: 490-494
3. O'Dea K. Preventable chronic diseases among Indigenous australians: the need for a comprehensive national approach. Heart Lung Circ. 2005 ; 14: 167-171
4. Shah BR, Hux JE, Zinman B. Increasing rates of ischemic heart disease in the native population of Ontario, Canada. Arch Inter Med. 2000 ; 160: 1862-1866
5. Zhang Y, Galloway JM, Welty TK, et al. Incidence and risk factor for stroke in American Indians the strong heart study. Circulation. 2008 ; 118: 1577-1584
6. Spranger J, Kroke A, Mohlig M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes. Diabetes. 2003 ; 52: 812-817
7. Tuttle HA, David-Gorman G, Goldman S, et al. Proinflammatory cytokines are increased in type 2 diabetic women with cardiovascular disease. J Diabetes Complications. 2004 ; 18: 343-351
8. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus. JAMA. 2001 ; 286: 327-334
9. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000 ; 342: 836-843
10. Pai JK, Pischon T, Ma J, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004 ; 351: 2599-2610
11. Seyrek N, Karayaylali I, Balal M, et al. Is there any relationship between serum levels of interluekin-10 and atherosclerosis in hemodialysis patients?. Scand J Urol Nephrol. 2005 ; 39: 405-409
12. Heeschen C, Dimmeler S, Hamm CW, et al. Serum level of the antiinflammatory cytokine Interluekin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation. 2003 ; 107: 2109-2114
13. Volpato S, Guralnik JM, Ferrucci L, et al. Cardiovascular disease, Interleukin-6, and risk of mortality in older women: The women's health and aging study. Circulation. 2001 ; 103: 947-953
14. Oberg BP, McMenamin E, Lucas FL, et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int. 2004 ; 65: 1009-1016
15. Decamps-Latscha B, Hebelin A, Nguyen AT, et al. Balance between IL-1B, TNF-A, and their specific inhibitors in chronic renal failure and maintenance dialysis. J Immunol. 1995 ; 154: 882-892
16. Moscovis SM, Gordon AE, Hall ST, et al. Interleukin-1B responses to bacterial toxins and sudden infant death syndrome. FEMS Immunol Med Microbiol. 2004 ; 42: 139-145
17. Moscovis SM, Gordon AE, Madani OMA, et al. Interleukin-10 and sudden infant death syndrome. FEMS Immunol Med Microbiol. 2004 ; 42: 130-138
18. Moscovis SM, Gordon AE, Madani OMA, et al. IL6 G-174C associated with sudden infant death syndrome in a caucasian australian cohort. Hum Immunol. 2006 ; 67: 819-825
19. Meenagh A, Williams F, Ross OA, et al. Frequency of cytokine polymorphisms in populations from western europe, africa, asia, the middle east and south america. Hum Immunol. 2002 ; 63: 1055-1061
20. Delaney NL, Esquenazi V, Lucas DP, et al. TNF-A, TGF-b, IL-10, IL-6, and IFN-g alleles among African Americans and Cuban Americans. Hum Immunol. 2004 ; 65: 1413-1419
21. Ma X, Reich RA, Wright JA, et al. Association between interleukin-8 gene alleles and human susceptibility to tuberculosis disease. J Infect Dis. 2003 ; 188: 349-355
22. Larcombe LA, Orr PH, Lodge AM, et al. Function gene polymorphisms in canadian aboriginal populations with high rates of tuberculosis. J Infect Dis. 2008 ; 198: 1175-1179
23. Ridker PM. On evolutionary biology, inflammation, infection and the causes of atherosclerosis. Circulation. 2002 ; 105: 2-4
24. Marshall OJ. PerlPrimer: cross-platform, graphical primer design for standard, bisulphite and real-time PCR. Bioinformatics. 2004 ; 20: 2471-2472
25. Smith PJ, Zhang C, Wang J, et al. An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum Mol Genet. 2006 ; 15: 2490-2508
26. Cartegni L, Wang J, Zhu Z, et al. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res. 2003 ; 31: 3568-3571
27. Yuan H, Chiou J, Tseng W, et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res. 2006 ; 34: W635 - W641
28. Tishkoff SA, Williams SM. Genetic analysis of african populations: Human evolution and complex disease. Nat Rev Genet. 2002 ; 3: 611-621
29. Lango H, Weedon MN. What will whole genome searches for susceptibility genes for common complex disease offer to clinical practice?. J Intern Med. 2007 ; 262: 16-27
30. Stolerman ES, Florez JC. Genomics for type 2 diabetes mellitus: implications for the clinician. Nat Rev Endocrinol. 2009 ; 5: 429-436
31. Daley GQ, Cargill M. The heart SNPs a beat: Polymorphisms in candidate genes for cardiovascular disease. Trends Cardiovasc Med. 2001 ; 11: 60-66
32. Rasmussen M, Guo X, Wang Y, et al. An Aboriginal Australian genome reveals separate human dispersals into Asia. Science. 2011 ; 334: 94-98